Skip to main content
Erschienen in: Sleep and Breathing 2/2021

01.08.2020 | Sleep Breathing Physiology and Disorders • Short Communication

Obstructive sleep apnea syndrome and autonomic dysfunction in Duchenne muscular dystrophy

verfasst von: Gulcin Benbir Senel, N. Burcu Arkali, Huseyin Kilic, Gunduz Incesu, Sema Saltik, Cengiz Yalcinkaya, Derya Karadeniz

Erschienen in: Sleep and Breathing | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cardiac and respiratory involvement constitutes serious complications of Duchenne muscular dystrophy (DMD). We hypothesized that obstructive sleep apnea syndrome (OSAS) may play a role in cardiac autonomic dysfunction in DMD. We sought to assess the presence of cardiac autonomic function in patients with DMD by analyzing heart rate variability (HRV) during polysomnography (PSG).

Methods

In a prospective study, all participants had whole-night PSG recorded and scored according to American Academy of Sleep Medicine guidelines. HRV analysis was performed on electrocardiography recordings from PSG recordings.

Results

Twelve consecutive males with DMD (mean age 9.0 ± 3.1 years, mean BMI 20.6 ± 4.8 kg/m2) and eight age-matched healthy males were enrolled. On clinical evaluation, 58% of patients with DMD had at least one symptom related to OSAS, such as snoring, witnessed apnea, or restless sleep. None of the controls had OSAS-related complaints. By PSG none of the controls had OSAS, while 42% of patients with DMD had OSAS (p = 0.004). Average R-R duration and mean percentage of successive R-R intervals > 50 ms values were significantly lower in patients with DMD than those in controls (p < 0.006). In patients with DMD and OSAS, LF/HF (low/high-frequency) ratio was significantly increased in NREM sleep compared with those in controls (p = 0.005). Higher apnea-hypopnea index and lower oxygen saturation showed significant correlations with higher LF power and LF/HF ratio (p < 0.001).

Conclusion

Cardiac autonomic dysfunction is present in DMD, being more pronounced in the presence of OSAS.
Literatur
1.
Zurück zum Zitat Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRef Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRef
2.
Zurück zum Zitat Fayssoil A, Abasse S, Silverston K (2017) Cardiac involvement classification and therapeutic management in patients with Duchenne muscular dystrophy. J Neuromusc Dis 4:17–23CrossRef Fayssoil A, Abasse S, Silverston K (2017) Cardiac involvement classification and therapeutic management in patients with Duchenne muscular dystrophy. J Neuromusc Dis 4:17–23CrossRef
3.
Zurück zum Zitat Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44:8–19CrossRef Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44:8–19CrossRef
4.
Zurück zum Zitat Ashwath ML, Jacobs IB, Crowe CA, Ashwath RC, Super DM, Bahler RC (2014) Left ventricular dysfunction in muscular dystrophy and genotype. Am J Cardiol 114:284–289CrossRef Ashwath ML, Jacobs IB, Crowe CA, Ashwath RC, Super DM, Bahler RC (2014) Left ventricular dysfunction in muscular dystrophy and genotype. Am J Cardiol 114:284–289CrossRef
5.
Zurück zum Zitat Thayer JF, Yamamoto SS, Brosschot JF (2010) The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 141:122–131CrossRef Thayer JF, Yamamoto SS, Brosschot JF (2010) The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 141:122–131CrossRef
6.
Zurück zum Zitat Inoue M, Mori K, Hayabuchi Y, Tatara K, Kagami S (2009) Autonomic function in patients with duchenne muscular dystrophy. Pediatr Int 51:33–40CrossRef Inoue M, Mori K, Hayabuchi Y, Tatara K, Kagami S (2009) Autonomic function in patients with duchenne muscular dystrophy. Pediatr Int 51:33–40CrossRef
7.
Zurück zum Zitat Thomas TO, Morgan TM, Burnette WB, Markham LW (2012) Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy. Pediatr Cardiol 33:1175–1179CrossRef Thomas TO, Morgan TM, Burnette WB, Markham LW (2012) Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy. Pediatr Cardiol 33:1175–1179CrossRef
8.
Zurück zum Zitat Thomas TO, Jefferies JL, Lorts A, Anderson JB, Gao Z, Benson DW et al (2015) Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients? Pediatr Cardiol 36:561–568CrossRef Thomas TO, Jefferies JL, Lorts A, Anderson JB, Gao Z, Benson DW et al (2015) Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients? Pediatr Cardiol 36:561–568CrossRef
9.
Zurück zum Zitat Sawnani H (2019) Sleep disordered breathing in Duchenne muscular dystrophy. Paediatr Respir Rev 30:2–8PubMed Sawnani H (2019) Sleep disordered breathing in Duchenne muscular dystrophy. Paediatr Respir Rev 30:2–8PubMed
10.
Zurück zum Zitat Flevari A, Vagiakis E, Zakynthinos S (2015) Heart rate variability is augmented in patients with positional obstructive sleep apnea, but only supine LF/HF index correlates with its severity. Sleep Breath 19:359–367CrossRef Flevari A, Vagiakis E, Zakynthinos S (2015) Heart rate variability is augmented in patients with positional obstructive sleep apnea, but only supine LF/HF index correlates with its severity. Sleep Breath 19:359–367CrossRef
11.
Zurück zum Zitat Gula L, Krahn A, Skanes A, Ferguson KA, George C, Yee R et al (2003) Heart rate variability in obstructive sleep apnea: a prospective study and frequency domain analysis. Ann Noninvasive Electrocardiol 8:144–149CrossRef Gula L, Krahn A, Skanes A, Ferguson KA, George C, Yee R et al (2003) Heart rate variability in obstructive sleep apnea: a prospective study and frequency domain analysis. Ann Noninvasive Electrocardiol 8:144–149CrossRef
12.
Zurück zum Zitat Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485–491CrossRef Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485–491CrossRef
13.
Zurück zum Zitat American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
14.
Zurück zum Zitat Berry RB, Albertario CL, Harding SM, for the American Academy of Sleep Medicine (2018) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine, Darien Berry RB, Albertario CL, Harding SM, for the American Academy of Sleep Medicine (2018) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine, Darien
15.
Zurück zum Zitat Lanza GA, Dello Russo A, Giglio V, De Luca L, Messano L, Santini C et al (2001) Impairment of cardiac autonomic function in patients with duchenne muscular dystrophy: relationship to myocardial and respiratory function. Am Heart J 141:808–812CrossRef Lanza GA, Dello Russo A, Giglio V, De Luca L, Messano L, Santini C et al (2001) Impairment of cardiac autonomic function in patients with duchenne muscular dystrophy: relationship to myocardial and respiratory function. Am Heart J 141:808–812CrossRef
16.
Zurück zum Zitat Mosqueira M, Zeiger U, Forderer M, Brinkmeier H, Fink RH (2013) Cardiac and respiratory dysfunction in duchenne muscular dystrophy and the role of second messengers. Med Res Rev 33:1174–1213CrossRef Mosqueira M, Zeiger U, Forderer M, Brinkmeier H, Fink RH (2013) Cardiac and respiratory dysfunction in duchenne muscular dystrophy and the role of second messengers. Med Res Rev 33:1174–1213CrossRef
Metadaten
Titel
Obstructive sleep apnea syndrome and autonomic dysfunction in Duchenne muscular dystrophy
verfasst von
Gulcin Benbir Senel
N. Burcu Arkali
Huseyin Kilic
Gunduz Incesu
Sema Saltik
Cengiz Yalcinkaya
Derya Karadeniz
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 2/2021
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02139-5

Weitere Artikel der Ausgabe 2/2021

Sleep and Breathing 2/2021 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Review

Obstructive sleep apnea and respiratory center regulation abnormality

Sleep Breathing Physiology and Disorders • Short Communication

Long-term effectiveness of CPAP in patients with severe obesity-hypoventilation syndrome

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.